Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Using Circulating Tumor DNA to Spare Patients with Diffuse Large B-cell Lymphoma Unnecessary Treatment and Cost: a Model-based Analysis
December 13, 2024 | Poster
Circulating tumor DNA clearance by neoadjuvant chemotherapy or breast surgery detected using an ultra-sensitive ctDNA MRD assay in early breast cancer
December 13, 2024 | Poster
Baseline prognostic factors do not predict end of treatment ctDNA MRD status and have limited impact on MRD prognostic performance in DLBCL
December 12, 2024 | Presentation
High rates of undetectable MRD by PhasED-Seq on interim and end of treatment timepoints in untreated advanced stage CHL treated with pembrolizumab + AVD
December 12, 2024 | Poster
The role of MRD-based recurrence detection in early stage lung and breast cancer
November 20, 2024 | Video
Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
September 16, 2024 | Poster